"Atlanta Braves designated hitter Jurickson Profar is facing a 162-game suspension after testing positive for a performance-enhancing drug for the second time, sources told ESPN. Coming off a career year in San Diego in 2024, Profar signed a three-year, $42 million contract last offseason with the Braves."
"Suddenly, the Braves are down an outfield starter and an impactful bat, without any real time or market opportunity to replace him. It's a huge blow to a club that is already facing injury issues all over its rotation, and was nevertheless seen as a top-tier contender in the NL."
"Profar, 33, was at one time considered among the best prospects in baseball. Injuries piled up in his younger days and kinda set his career off course, but he had rebounded here in his early-30s. Now that all gets cast in a very different light, and his future in MLB is in doubt."
Jurickson Profar, the Atlanta Braves' designated hitter, has been suspended for 162 games following a second positive test for performance-enhancing drugs. This marks his second violation after previously testing positive and serving a half-season suspension. Profar signed a three-year, $42 million contract with the Braves after a career year with San Diego in 2024. His suspension removes a key offensive contributor from the lineup and compounds existing injury problems throughout the team's rotation. The Braves, considered top-tier NL contenders, now face significant roster challenges with limited time to find replacement options. Profar, 33, will forfeit his salary during the suspension, though he remains under contract for $15 million in 2027. His future in Major League Baseball is now uncertain.
#performance-enhancing-drugs #mlb-suspension #atlanta-braves #jurickson-profar #baseball-roster-impact
Read at Bleacher Nation
Unable to calculate read time
Collection
[
|
...
]